More information: Alexandra Blackman et al, MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine ...

A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

Combination of Cancer Vaccine and T Cell Therapy Benefits ... The researchers successfully deployed CAR-T in a mouse model of ovarian ... July 21, 2023 — A preclinical study showed that ...

"The question was, to what extent all of the cells contribute to ovarian cancer," explains Nikitin. Unlike in the ovaries, ...

Ovarian cancer is when abnormal cells in the ovary begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer cells gradually grow into the ...

Ovarian cancer is when abnormal cells in the ovary begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer cells gradually grow into the ...

positive platinum-resistant ovarian cancer. Roche's VENTANA RxDx Assay is a qualitative immunohistochemical assay using mouse monoclonal anti-FOLR1 clone FOLR1-2.1 intended for use in the ...

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...